Annexon, Inc. - ANNX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | — | P | A | 8,000.0 | 6.2 | 49,600.0 | 70,405.0 | View | |
| Mar 12, 2026 | — | P | A | 8,000.0 | 5.67 | 45,360.0 | 62,405.0 | View | |
| Mar 04, 2026 | EVP & CHIEF SCIENTIFIC OFFICER | S | D | 5,894.0 | 5.43 | 32,004.42 | 180,093.0 | View | |
| Mar 04, 2026 | CHIEF MEDICAL OFFICER | S | D | 5,820.0 | 5.43 | 31,602.6 | 123,582.0 | View | |
| Mar 04, 2026 | EVP & CHIEF INNOVATION OFFICER | S | D | 5,566.0 | 5.42 | 30,167.72 | 154,161.0 | View | |
| Mar 04, 2026 | EVP & CHIEF BUSINESS OFFICER | S | D | 4,339.0 | 5.42 | 23,517.38 | 182,625.0 | View | |
| Mar 04, 2026 | EVP & CHIEF FINANCIAL OFFICER | S | D | 5,565.0 | 5.42 | 30,162.3 | 170,700.0 | View | |
| Feb 23, 2026 | EVP & CHIEF FINANCIAL OFFICER | A | A | 250,000.0 | 0.0 | 0.0 | 250,000.0 | View | |
| Feb 23, 2026 | EVP & CHIEF FINANCIAL OFFICER | A | A | 62,500.0 | 0.0 | 0.0 | 176,265.0 | View | |
| Feb 23, 2026 | EVP & CHIEF INNOVATION OFFICER | A | A | 250,000.0 | 0.0 | 0.0 | 250,000.0 | View | |
| Feb 23, 2026 | EVP & CHIEF INNOVATION OFFICER | A | A | 62,500.0 | 0.0 | 0.0 | 159,727.0 | View | |
| Feb 23, 2026 | EVP & CHIEF SCIENTIFIC OFFICER | A | A | 250,000.0 | 0.0 | 0.0 | 250,000.0 | View | |
| Feb 23, 2026 | EVP & CHIEF SCIENTIFIC OFFICER | A | A | 62,500.0 | 0.0 | 0.0 | 185,987.0 | View | |
| Feb 23, 2026 | EVP & CHIEF BUSINESS OFFICER | A | A | 250,000.0 | 0.0 | 0.0 | 250,000.0 | View | |
| Feb 23, 2026 | EVP & CHIEF BUSINESS OFFICER | A | A | 62,500.0 | 0.0 | 0.0 | 186,964.0 | View | |
| Feb 23, 2026 | CHIEF MEDICAL OFFICER | A | A | 225,000.0 | 0.0 | 0.0 | 225,000.0 | View | |
| Feb 23, 2026 | CHIEF MEDICAL OFFICER | A | A | 56,250.0 | 0.0 | 0.0 | 129,402.0 | View | |
| Feb 23, 2026 | PRESIDENT AND CEO | A | A | 1,250,000.0 | 0.0 | 0.0 | 1,250,000.0 | View | |
| Feb 20, 2026 | EVP & CHIEF BUSINESS OFFICER | S | D | 6,225.0 | 5.1 | 31,747.5 | 124,464.0 | View | |
| Feb 20, 2026 | EVP & CHIEF INNOVATION OFFICER | S | D | 7,857.0 | 5.11 | 40,149.27 | 97,227.0 | View | |
| Feb 20, 2026 | EVP & CHIEF SCIENTIFIC OFFICER | S | D | 5,290.0 | 5.1 | 26,979.0 | 123,487.0 | View | |
| Feb 20, 2026 | EVP & CHIEF FINANCIAL OFFICER | S | D | 7,851.0 | 5.11 | 40,118.61 | 113,765.0 | View | |
| Feb 20, 2026 | CHIEF MEDICAL OFFICER | S | D | 5,290.0 | 5.1 | 26,979.0 | 73,152.0 | View | |
| Jan 02, 2026 | — | P | A | 4,115.0 | 5.02 | 20,657.3 | 54,405.0 | View | |
| Dec 03, 2025 | — | P | A | 33,000.0 | 4.19 | 138,270.0 | 33,000.0 | View | |
| Dec 03, 2025 | — | P | A | 4,115.0 | 4.47 | 18,394.05 | 50,290.0 | View | |
| Nov 21, 2025 | — | P | A | 422,613.0 | 4.28 | 1,808,783.64 | 9,728,637.0 | View | |
| Nov 21, 2025 | — | P | A | 400,000.0 | 4.48 | 1,792,000.0 | 9,306,024.0 | View | |
| Nov 19, 2025 | — | P | A | 500,000.0 | 3.94 | 1,970,000.0 | 8,906,024.0 | View | |
| Nov 19, 2025 | — | P | A | 500,000.0 | 3.18 | 1,590,000.0 | 8,406,024.0 | View | |
| Nov 19, 2025 | — | P | A | 500,000.0 | 2.99 | 1,495,000.0 | 7,906,024.0 | View | |
| Oct 31, 2025 | — | P | A | 4,115.0 | 3.17 | 13,044.55 | 46,175.0 | View |